NZHR has made a submission on the Therapeutic Products Bill. Because products used in clinical trials are yet to be confirmed or otherwise as being therapeutic they need to be unambiguously exempted from many of the Bill’s provisions. It is also important that the new legislation does not impose additional burdens on the carrying out of clinical trials, and we have canvassed both of these issues in our submission which can be read here